Trial intelligence / Profile preview

Bevacizumab in Trabeculectomy Surgery

NCT01166594Phase 4Completed

Sponsor
Sunnybrook Health Sciences Centre
Start
Jun 2010
Primary completion
Sep 2013
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of bevacizumab in Glaucoma, sponsored by Sunnybrook Health Sciences Centre. Started Jun 2010; status: completed.

02

Drugs

bevacizumab
03

Conditions

Glaucoma

Beyond the preview

Go deeper on NCT01166594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01166594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call